Enantiomer specific pharmacokinetics.

To indicate the extent of differences in the pharmacokinetics of enantiomers with respect to absorption and disposition phenomena. To emphasise the potential benefits of studying enantiospecific pharmacokinetics, that is, kinetics based on the measurement of the time-course of separate isomers rather than of the total, racemic drug mixture

[1]  K. Kawashima,et al.  Stereospecific radioimmunoassay for propranolol isomers. , 1976, The Journal of pharmacology and experimental therapeutics.

[2]  A Yacobi,et al.  Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats. , 1984, The Journal of pharmacology and experimental therapeutics.

[3]  K. Giacomini,et al.  Stereoselective renal clearance of pindolol in humans. , 1985, The Journal of clinical investigation.

[4]  S. Winter,et al.  The pharmacological and toxicological significance of the stereochemistry of drug disposition. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  M. Fasco,et al.  R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat. , 1982, The Journal of biological chemistry.

[6]  P. Meffin,et al.  The stereospecific incorporation of fenoprofen into rat hepatocyte and adipocyte triacylglycerols. , 1988, Biochemical pharmacology.

[7]  K. P. Link,et al.  A comparison of the isomers of warfarin , 1966 .

[8]  R. O'Reilly.  Stereoselective Interaction of Sulfinpyrazone with Racemic Warfarin and Its Separated Enantiomorphs in Man , 1982, Circulation.

[9]  G. Tucker.  PHARAMACOKINETICS OF LOCAL ANAESTHETICS , 1986 .

[10]  W. Trager,et al.  Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man. , 1980, The Journal of clinical investigation.

[11]  L. Sansom,et al.  Stereoselective drug disposition: potential for misinterpretation of drug disposition data. , 1988, British journal of clinical pharmacology.

[12]  D. Shand,et al.  The Disposition of Propranolol , 1972 .

[13]  W. Trager,et al.  Interaction of secobarbital with warfarin pseudoracemates , 1980, Clinical pharmacology and therapeutics.

[14]  Paolo Negro,et al.  Anti‐inflammatory activity of a polysaccharidic fraction of Echinacea angustifolia , 1987, The Journal of pharmacy and pharmacology.

[15]  H. Thijssen,et al.  Vitamin K 2,3‐epoxide reductase: the basis for stereoselectivity of 4‐hydroxycoumarin anticoagulant activity , 1988, British journal of pharmacology.

[16]  T. Meinertz,et al.  The enantiomers of phenprocoumon: Pharmacodynamic and pharmacokinetic studies , 1976, Clinical pharmacology and therapeutics.

[17]  R. Day,et al.  Stereoselective disposition of ibuprofen enantiomers in synovial fluid , 1988, Clinical pharmacology and therapeutics.

[18]  M. Rowland,et al.  Stereospecific assay of nicoumalone: application to pharmacokinetic studies in man. , 1988, British journal of clinical pharmacology.

[19]  H. Nau,et al.  The enantiomers of the teratogenic thalidomide analogue EM 12. 2. Chemical stability, stereoselectivity of metabolism and renal excretion in the marmoset monkey. , 1989 .

[20]  D. Drayer.  Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview , 1986, Clinical pharmacology and therapeutics.

[21]  R. Reilly.  Studies on the optical enantiomorphs of warfarin in man , 1974 .

[22]  T. Moyer,et al.  Serum tocainide enantiomer concentrations in human subjects. , 1984, British journal of clinical pharmacology.

[23]  G. Tucker,et al.  Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes. , 1988, The Journal of pharmacology and experimental therapeutics.

[24]  A. Breckenridge,et al.  The plasma half lives and the pharmacological effect of the enantiomers of warfarin in rats. , 1972, Life sciences. Pt. 2: Biochemistry, general and molecular biology.

[25]  R. Le Verge,et al.  Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[26]  J. Morris,et al.  Active Transport of L-Dopa in the Intestine , 1973, Nature.

[27]  M. Gibaldi,et al.  The warfarin‐sulfinpyrazone interaction: stereochemical considerations , 1986, Clinical pharmacology and therapeutics.

[28]  W. Trager,et al.  Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans , 1987, Clinical pharmacology and therapeutics.

[29]  W. Rummel,et al.  Stereospecificity of anesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates. , 1970, The Journal of pharmacology and experimental therapeutics.

[30]  H. Boudoulas,et al.  Stereoselective pharmacokinetics of disopyramide enantiomers in man. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[31]  D. Roden,et al.  Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences. , 1987, Circulation.

[32]  E. Chan,et al.  Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. , 1983, British journal of clinical pharmacology.

[33]  T. Walle,et al.  Stereoselective secretion of atenolol from PC12 cells. , 1988, The Journal of pharmacology and experimental therapeutics.

[34]  A. Breckenridge,et al.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. , 1974, The Journal of clinical investigation.

[35]  S K Yang,et al.  Stereoselectivity of cytochrome P-450 isozymes and epoxide hydrolase in the metabolism of polycyclic aromatic hydrocarbons. , 1988, Biochemical pharmacology.

[36]  A. Karim,et al.  Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog. , 1982, Drug metabolism and disposition: the biological fate of chemicals.

[37]  M. Eichelbaum,et al.  Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis. , 1981, British journal of clinical pharmacology.

[38]  T. Walle,et al.  Stereoselective delivery and actions of beta receptor antagonists. , 1988, Biochemical pharmacology.

[39]  H. Nau,et al.  Embryotoxic effects of thalidomide derivatives on the non-human primate Callithrix jacchus; 3. Teratogenic potency of the EM 12 enantiomers. , 1988, Archives of toxicology.

[40]  E. Smith,et al.  Stereoselectivity of tocainide pharmacodynamics in vivo and in vitro. , 1988, Journal of cardiovascular pharmacology.

[41]  D. Shand,et al.  Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate. , 1973, American heart journal.

[42]  R. O'Reilly.  Ticrynafen‐racemic warfarin interaction: Hepatotoxic or stereoselective? , 1982, Clinical pharmacology and therapeutics.

[43]  J. Huang.  Stereoselective gastrointestinal clearance of disopyramide in rabbits treated with activated charcoal. , 1988, Journal of pharmaceutical sciences.

[44]  M. Gibaldi,et al.  The mechanism of the warfarin‐rifampin drug interaction in humans , 1987, Clinical pharmacology and therapeutics.

[45]  M. Eichelbaum,et al.  Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. , 1984, British journal of clinical pharmacology.

[46]  T. Walle,et al.  Pharmacokinetic parameters obtained with racemates , 1986 .

[47]  J. W. Cox,et al.  Ibuprofen stereoisomer hepatic clearance and distribution in normal and fatty in situ perfused rat liver. , 1985, The Journal of pharmacology and experimental therapeutics.

[48]  A. Breckenridge,et al.  Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man , 1974, Clinical pharmacology and therapeutics.

[49]  H. Thijssen,et al.  The biliary excretion of acenocoumarol in the rat: stereochemical aspects , 1987, The Journal of pharmacy and pharmacology.

[50]  J. Caldwell,et al.  The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. , 1988, Biochemical pharmacology.

[51]  F. Ludueña.  Duration of local anesthesia. , 1969, Annual review of pharmacology.

[52]  F. Deluna,et al.  Stereospecific binding of timolol, a beta-adrenergic blocking agent. , 1976, Drug metabolism and disposition: the biological fate of chemicals.

[53]  R. Day,et al.  Stereoselective disposition of ibuprofen enantiomers in infants. , 1985 .

[54]  Y. Nakamura,et al.  Stereoselective metabolism of 2-phenylpropionic acid in rat. II. Studies on the organs responsible for the optical isomerization of 2-phenylpropionic acid in rat in vivo. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[55]  Grant R. Wilkinson,et al.  A physiological approach to hepatic drug clearance , 1975 .

[56]  E. Sellers,et al.  Methadone binding to orosomucoid (α1‐acid glycoprotein): Determinant of free fraction in plasma , 1981 .

[57]  L. B. Wingard,et al.  Pharmacokinetics of warfarin enantiomers: A search for intrasubject correlations , 1978, Clinical pharmacology and therapeutics.

[58]  M. Eichelbaum,et al.  Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration. , 1984, British journal of clinical pharmacology.

[59]  A. Breckenridge,et al.  Stereoselective interaction between the R enantiomer of warfarin and cimetidine. , 1986, British journal of clinical pharmacology.

[60]  D. Shand,et al.  Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in Man , 1970, British medical journal.

[61]  G. Tucker,et al.  Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers , 1983, Clinical pharmacology and therapeutics.

[62]  T. Butler,et al.  Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation reactions in man and the dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[63]  T. Walle,et al.  Stereoselective binding of the (-)-enantiomer of propranolol to plasma and extravascular binding sites in the dog. , 1983, Drug Metabolism And Disposition.

[64]  H. Ogata,et al.  Determination of propranolol enantiomers in human plasma and urine and in rat tissues using chiral stationary-phase liquid chromatography. , 1988, Journal of pharmaceutical sciences.

[65]  J. Paulson,et al.  Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. , 1989, British journal of clinical pharmacology.

[66]  G. Åberg.  Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. , 1972, Acta pharmacologica et toxicologica.

[67]  I. Tamai,et al.  Stereospecific Absorption and Degradation of Cephalexin , 1988, The Journal of pharmacy and pharmacology.

[68]  L. Aarons,et al.  Enoxacin‐warfarin interaction: Pharmacokinetic and stereochemical aspects , 1987, Clinical pharmacology and therapeutics.

[69]  D. Drayer,et al.  Pharmacokinetics of pentobarbital enantiomers as determined by enantioselective radioimmunoassay after administration of racemate to humans and rabbits. , 1987, The Journal of pharmacology and experimental therapeutics.

[70]  C. Kerr,et al.  Stereoselective serum protein binding of mexiletine enantiomers in man. , 1987, Research communications in chemical pathology and pharmacology.

[71]  R. O'Reilly.  Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man. , 1980, The New England journal of medicine.

[72]  T. Meinertz,et al.  Pharmacokinetics of the enantiomers of acenocoumarol in man. , 1981, British journal of clinical pharmacology.

[73]  H. Persson,et al.  Local anaesthetic properties of the optically active isomers of prilocaine (Citanest). , 2009, Acta pharmacologica et toxicologica.

[74]  D. Notterman,et al.  Stereoselective renal tubular secretion of quinidine and quinine , 1986, Clinical pharmacology and therapeutics.

[75]  W. Hillis,et al.  The pharmacokinetics of R- and S-tocainide in patients with acute ventricular arrhythmias. , 1986, British journal of clinical pharmacology.

[76]  M. Eichelbaum,et al.  Effects of d,l‐verapamil on atrioventricular conduction in relation to its stereoselective first‐pass metabolism , 1985, Clinical pharmacology and therapeutics.

[77]  J. Turgeon,et al.  Stereoselective disposition of mexiletine in man. , 1986, British journal of clinical pharmacology.

[78]  R. Branch,et al.  Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities , 1989, Clinical pharmacology and therapeutics.

[79]  R. O'Reilly.  The stereoselective interaction of warfarin and metronidazole in man. , 1976, The New England journal of medicine.

[80]  B. Testa,et al.  Metabolic chiral inversion of anti-inflammatory 2-arylpropionates: lack of reaction in liver homogenates, and study of methine proton acidity. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[81]  A. Sedman,et al.  Serum binding of tocainide and its enantiomers in human subjects. , 1982, Research communications in chemical pathology and pharmacology.

[82]  R. Branch,et al.  The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver. , 1973, Drug metabolism and disposition: the biological fate of chemicals.

[83]  R. Blouin,et al.  Age‐associated stereoselective alterations in hexobarbital metabolism , 1988, Clinical pharmacology and therapeutics.

[84]  K. Williams,et al.  The stereoselective uptake of ibuprofen enantiomers into adipose tissue. , 1986, Biochemical pharmacology.

[85]  F. Reynolds,et al.  An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine. , 1978, British journal of clinical pharmacology.

[86]  Ö. Ericsson,et al.  Enantioselective Analysis of Chloroquine and Desethylchloroquine after Oral Administration of Racemic Chloroquine , 1986, Therapeutic drug monitoring.

[87]  D. Azarnoff,et al.  Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH , 1978, Clinical pharmacology and therapeutics.

[88]  C Y Quon,et al.  Species differences in the stereoselective hydrolysis of esmolol by blood esterases. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[89]  J. Thompson,et al.  Glucuronidation of propranolol by dog liver microsomes. Effects of enantiomeric inhibition and detergent treatment on stereoselectivity. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[90]  T. Walle,et al.  Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique. , 1979, Research communications in chemical pathology and pharmacology.

[91]  P. Murphy,et al.  Effect of l-propoxyphene on plasma levels and analgesic activity of d-propoxyphene in the rat. , 1976, The Journal of pharmacology and experimental therapeutics.

[92]  M. Eichelbaum,et al.  Pharmacokinetic and pharmacodynamic consequences of stereoselective drug metabolism in man. , 1988, Biochemical pharmacology.